A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer

Manpreet Sambi,1 Vanessa Samuel,1,2 Bessi Qorri,1 Sabah Haq,1,3 Sergey V Burov,4 Elena Markvicheva,5 William Harless,6 Myron R Szewczuk1 1Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada; 2Faculty of Medicine, University of British Columbia, Vancouv...

Full description

Bibliographic Details
Main Authors: Sambi M, Samuel V, Qorri B, Haq S, Burov SV, Markvicheva E, Harless W, Szewczuk MR
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:Drug Design, Development and Therapy
Subjects:
mda-mb231
mda-mb231-tmxr
human umbilical vein endothelial cell lines
multicellular tumour spheroids (mcts)
endothelial cell tube formation
apoptosis
Online Access:https://www.dovepress.com/a-triple-combination-of-metformin-acetylsalicylic-acid-and-oseltamivir-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/a-triple-combination-of-metformin-acetylsalicylic-acid-and-oseltamivir-peer-reviewed-article-DDDT

Similar Items